What is DA Davidson's price target for MED?

DA Davidson's latest stated price target for MEDIFAST INC (MED) is $17, from its action on Nov 5, 2024.

What is DA Davidson's rating on MED?

DA Davidson rates MED Neutral, a neutral rating, as of Nov 5, 2024.

When did DA Davidson last change its view on MED?

On Nov 5, 2024, DA Davidson upgrades to Neutral from Underperform, price target $16.50 to $17.

DA Davidson MED price target and rating history

DA Davidson rates MEDIFAST INC (MED) Neutral with a $17 price target, as of its latest action on Nov 5, 2024. It has published 5 rating actions on MED since November 2021, including 1 upgrade and 2 downgrades.

Current rating: Neutral
Price target: $17
Median target, all firms: Too few
Actions on MED: 5

DA Davidson price target on MED

DA Davidson price target on MED, each point a stated target, November 2021 to November 2024.

Every DA Davidson rating on MED

Nov 5, 2024
UpgradeDA Davidson upgrades to Neutral from Underperform, price target $16.50 to $17
Jun 5, 2024
DowngradeDA Davidson downgrades to Underperform from Neutral, price target $25 to $17.50
Nov 4, 2022
DowngradeDA Davidson downgrades to Neutral from Buy, price target $278 to $106
Feb 24, 2022
ReiterateDA Davidson cuts its price target to $341 from $349, keeps Buy
Nov 8, 2021
ReiterateDA Davidson cuts its price target to $349 from $395, keeps Buy

Questions about DA Davidson and MED

What is DA Davidson's price target for MED?: DA Davidson's latest stated price target for MEDIFAST INC (MED) is $17, from its action on Nov 5, 2024.
What is DA Davidson's rating on MED?: DA Davidson rates MED Neutral, a neutral rating, as of Nov 5, 2024.
When did DA Davidson last change its view on MED?: On Nov 5, 2024, DA Davidson upgrades to Neutral from Underperform, price target $16.50 to $17.

All DA Davidson ratings MED news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.